Clinical trial
Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes
NCT07039981 is registered in ClinicalTrials.gov with Insulet Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Glucose Control Using a Next Generation Automated Insulin Delivery Algorithm in Adults With Type 2 Diabetes
- Lead sponsor
- Insulet Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 1, 2025
- Completion date
- May 6, 2026
- Enrollment
- 48 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.